Sameer Zar - The Royal Marsden

More documents

Recommendations

Info

The Royal Marsden Change Presentation title and date in Footer dd.mm.yyyy The current screening & surveillance practice for Oesophageal Adenocarcinoma?
31 The Royal Marsden Managing Cancer Risk in Barrett’s Oesophagus The management of patients with Barrett's oesophagus involves three major components: – Treatment of the associated GORD – Endoscopic surveillance to detect dysplasia – Treatment of dysplasia
Page 1 and 2: The Royal Marsden Barrett’s Oesop
Page 3 and 4: 3 The Royal Marsden Diagnosis of Ba
Page 5 and 6: 5 The Royal Marsden Clinical Featur
Page 7 and 8: 7 The Royal Marsden Risk Factors As
Page 9 and 10: 9 The Royal Marsden Change Presenta
Page 11 and 12: The Royal Marsden Change Presentati
Page 17 and 18: 17 The Royal Marsden Surveillance o
Page 19 and 20: 19 The Royal Marsden Risk Factors A
Page 21 and 22: 21 The Royal Marsden Screening For
Page 23 and 24: 23 The Royal Marsden Change Present
Page 25 and 26: 25 The Royal Marsden Screening and
Page 27 and 28: How to Improve Screening for Barret
Page 29: 29 The Royal Marsden Change Present
Page 35 and 36: 35 The Royal Marsden Cancer Risk in
Page 37 and 38: 37 The Royal Marsden Management of
Page 39 and 40: 39 The Royal Marsden Twice Daily do
Page 41 and 42: 41 The Royal Marsden Management of
Page 43 and 44: 43 The Royal Marsden Management opt
Page 49 and 50: 49 The Royal Marsden Endoscopic Muc
Page 53 and 54: 53 The Royal Marsden ESD for Barret
Page 55 and 56: 55 The Royal Marsden Endotherapy in
Page 57 and 58: The Royal Marsden Primary Preventio
Page 59: The Royal Marsden Conclusion - Scre

Sameer Zar - The Royal Marsden

Create successful ePaper yourself

Delete template?

Save as template?